Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Menkes

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
BMJ (Clinical Research Ed.)|June 12, 2019
The double edged sword of medicalising cannabisDavid B Menkes
The New Zealand Medical Journal|June 21, 2022
Psychedelic and related medicines at the end of lifeDavid B Menkes
BMJ (Clinical Research Ed.)|February 19, 2016
Alcohol and serious harms of antidepressant treatmentDavid B Menkes
The New Zealand Medical Journal|March 27, 2002
PHARMACopsychiatry: problematic but promisingDavid B Menkes
BMJ (Clinical Research Ed.)|February 6, 2019
Let's put clozapine in perspectiveDavid B Menkes
BMJ (Clinical Research Ed.)|May 16, 2018
What interests should be disclosed to journals?David B Menkes
The Journal of the American Academy of Psychiatry and the Law|July 18, 2006
The silent expertDavid B Menkes
The New Zealand Medical Journal|October 1, 2011
New Zealand doctors and the pharmaceutical industry--time to cut the cord?David B Menkes
BMJ (Clinical Research Ed.)|September 8, 2011
Tackling conflicts of interest. Conflicts of interest and drug informationDavid B Menkes
BMJ (Clinical Research Ed.)|November 30, 2018
Pharmacological interactions: more reason to regard alcohol as a drugDavid B Menkes
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|June 12, 2019
The double edged sword of medicalising cannabisDavid B Menkes
The New Zealand Medical Journal|June 21, 2022
Psychedelic and related medicines at the end of lifeDavid B Menkes
BMJ (Clinical Research Ed.)|February 19, 2016
Alcohol and serious harms of antidepressant treatmentDavid B Menkes
The New Zealand Medical Journal|March 27, 2002
PHARMACopsychiatry: problematic but promisingDavid B Menkes
BMJ (Clinical Research Ed.)|February 6, 2019
Let's put clozapine in perspectiveDavid B Menkes
BMJ (Clinical Research Ed.)|May 16, 2018
What interests should be disclosed to journals?David B Menkes
The Journal of the American Academy of Psychiatry and the Law|July 18, 2006
The silent expertDavid B Menkes
The New Zealand Medical Journal|October 1, 2011
New Zealand doctors and the pharmaceutical industry--time to cut the cord?David B Menkes
BMJ (Clinical Research Ed.)|September 8, 2011
Tackling conflicts of interest. Conflicts of interest and drug informationDavid B Menkes
BMJ (Clinical Research Ed.)|November 30, 2018
Pharmacological interactions: more reason to regard alcohol as a drugDavid B Menkes
Pageof 11